The first known meta-analysis of how SARS-CoV-2 variant type and time since infection influence long-COVID symptoms ties Omicron to brain fog and paresthesia (numbness and tingling), while earlier ...

The Red & Black is a 501c3 nonprofit. Please consider a one-time gift or become a monthly supporter. Cancel anytime. Since 2020, COVID-19 has surged across the nation and the world. With variants like ...

Harnessing the power of a single dose, this innovative vaccine offers a potent defense against both current and future COVID-19 threats. Study: A single-dose intranasal live-attenuated codon ...

A team has found two antibodies that can work together to neutralize the virus that causes COVID-19 in all its current known variations in a laboratory environment. More research is needed, but the ...

Invivyd, Inc. has announced new in vitro data showing that its monoclonal antibody PEMGARDA™ (pemivibart) maintains effective neutralizing activity against the prevalent LP.8.1 variant of SARS-CoV-2, ...

A Stanford-led team has found two antibodies that can work together to defeat all SARS-CoV-2 variants. More research is needed, but the approach could help in the development of treatments to keep ...

Covid has largely dropped out of the headlines, but the virus that causes it is still circulating. We ask what we should know about a new variant of SARS-CoV-2, the state of the Covid pandemic in 2025 ...

UCSF researchers designed new drug candidates that potently block MPro, a viral enzyme that's crucial for SARS-CoV-2 replication. One of these drug candidates, AVI-4516, is shown (center) bound to the ...